The store will not work correctly when cookies are disabled.
N-(1-methylcyclobutyl)-2-(pyrimidin-4-yl)-1,7-naphthyridin-4-amine
ID: ALA4483764
PubChem CID: 135390576
Max Phase: Preclinical
Molecular Formula: C17H17N5
Molecular Weight: 291.36
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC1(Nc2cc(-c3ccncn3)nc3cnccc23)CCC1
Standard InChI: InChI=1S/C17H17N5/c1-17(5-2-6-17)22-14-9-15(13-4-8-19-11-20-13)21-16-10-18-7-3-12(14)16/h3-4,7-11H,2,5-6H2,1H3,(H,21,22)
Standard InChI Key: XDCZJBKBUHYSNO-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 25 0 0 0 0 0 0 0 0999 V2000
7.2144 -4.2942 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7922 -3.7122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2102 -3.1344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6324 -3.7164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7779 -5.9231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2002 -5.9231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5047 -4.7026 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.2002 -6.7359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3596 -5.9231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0853 -7.1423 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3482 -7.9841 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.9259 -7.1423 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6210 -6.7333 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.6225 -8.3904 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7779 -6.7359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3596 -6.7359 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.3474 -7.1348 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9259 -7.9841 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0853 -5.5168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5035 -5.5168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5035 -7.1423 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.9206 -4.7082 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 1 1 0
17 11 2 0
5 20 2 0
8 6 2 0
9 16 1 0
13 17 1 0
14 11 1 0
19 9 2 0
8 21 1 0
13 12 2 0
18 14 2 0
15 10 1 0
10 16 2 0
15 5 1 0
20 6 1 0
12 18 1 0
20 7 1 0
5 19 1 0
21 15 2 0
8 12 1 0
7 1 1 0
1 22 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 291.36 | Molecular Weight (Monoisotopic): 291.1484 | AlogP: 3.44 | #Rotatable Bonds: 3 |
Polar Surface Area: 63.59 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 3.31 | CX LogP: 2.07 | CX LogD: 2.07 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.80 | Np Likeness Score: -0.48 |
References
1. (2018) 6-6 Fused Bicyclic Heteroaryl Compounds and their Use as LATS Inhibitors, |